|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Genomics & Proteomics | ||||||||||||||||
| November 29, 2001 | ||||||||||||||||
|
marcus evans, Hotel Beau-Rivage, Geneva, Switzerland 19-20 February 2002 - |
||||||||||||||||
| Organized by: | marcus evans | |||||||||||||||
| Invited Speakers: | Prof. Klaus Lindpaintner, Vice President and Director of Roche Genetics, F. HOFFMANN-LA ROCHE AG. Prof. Dalia Cohen, Vice President and Global Head of Functional Genomics, NOVARTIS PHARMACEUTICALS CORPORATION (US). Dr. Geoff Ginsburg, Vice President Molecular Medicine and Research Strategy, MILLENNIUM PHARMACEUTICALS INC. (US). Ph.D. Paul Rounding, Vice President Business Development, ARTEMIS PHARMACEUTICALS GMBH. Ph.D. Pierre Legrain, Vice President Science and Technology, HYBRIGENICS SA. Dr. Lee Beeley, Group Director Targets Genomics, PFIZER. Ph.D. Matthew Davison, Head of US Proteomics, AVENTIS PHARMACEUTICALS (US). Dr. Georg Feger, Department Head of Research & Pharmaceutical Development, SERONO SA. Dr. Scott Stanley, Senior Scientific Analyst, Population Genomics, GENAISSANCE PHARMACEUTICALS, INC. (US). Ph.D and Assoc. Prof. Staffan Lake, Senior Scientist, BIOVITRUM. Henri J. M. Theunissen, Manager Research Alliances, NV ORGANON. MD and Ph.D. Joshua Labaer, Director, HARVARD INSTITUTE OF PROTEOMICS (US). Peter James, Professor of Protein Technology, LUND INSTITUTE OF TECHNOLOGY. Ivar Roots, Professor of Clinical Pharmacology, HUMBOLDT-UNIVERSITY OF BERLIN. Dr. Gudrun Tiedemann, Director of Biotechnology, GERMAN FEDERATION OF THE PHARMACEUTICAL INDUSTRY. |
|||||||||||||||
| Deadline for Abstracts: | - | |||||||||||||||
| Registration: | - | |||||||||||||||
| E-mail: | olas@marcusevansuk.com | |||||||||||||||
| Posted by: | Ola Samuelsson | |||||||||||||||
| Host: | 194.74.216.2 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||